State Regulation of De-Identified Health Information


Manatt recently teamed with health care privacy expert Janlori Goldman of Columbia’s Mailman School of Public Health to explore the public policy ramifications of state efforts to regulate use of patient de-identified health information. In an article published in the April 6 issue of BNA’s Privacy & Security Law Report, they highlight the unintended consequences of restricting access to this information, which is integral to evaluating and improving health care quality.

The article comes on the heels of litigation between two health information companies and the state of New Hampshire, which passed a law that makes it a crime – a felony for businesses – to transfer or use for commercial purposes information about doctors’ prescribing behavior, including information that does not identify the patient.

Please see full newsletter for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Manatt, Phelps & Phillips, LLP | Attorney Advertising

Written by:


Manatt, Phelps & Phillips, LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.